{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:09:15Z","timestamp":1791295755090,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,1,20]],"date-time":"2009-01-20T00:00:00Z","timestamp":1232409600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1038\/sj.bjc.6604880","type":"journal-article","created":{"date-parts":[[2009,1,20]],"date-time":"2009-01-20T21:08:51Z","timestamp":1232485731000},"page":"551-557","source":"Crossref","is-referenced-by-count":143,"title":["Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis"],"prefix":"10.1038","volume":"100","author":[{"given":"C C","family":"Abnet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N D","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Kamangar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M F","family":"Leitzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A R","family":"Hollenbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Schatzkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,1,20]]},"reference":[{"key":"BF6604880_CR1","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.ejca.2007.12.009","volume":"44","author":"CC Abnet","year":"2008","unstructured":"Abnet CC, Freedman ND, Hollenbeck AR, Fraumeni Jr JF, Leitzmann M, Schatzkin A (2008) A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma. Eur J Cancer 44: 465\u2013471","journal-title":"Eur J Cancer"},{"key":"BF6604880_CR2","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1054\/bjoc.2001.1702","volume":"84","author":"K Akre","year":"2001","unstructured":"Akre K, Ekstrom AM, Signorello LB, Hansson LE, Nyren O (2001) Aspirin and risk for gastric cancer: a population-based case\u2013control study in Sweden. Br J Cancer 84: 965\u2013968","journal-title":"Br J Cancer"},{"key":"BF6604880_CR3","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.1158\/0008-5472.CAN-05-4253","volume":"66","author":"LA Anderson","year":"2006","unstructured":"Anderson LA, Johnston BT, Watson RGP, Murphy SJ, Ferguson HR, Comber H, McGuigan J, Reynolds JV, Murray LJ (2006) Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence. Cancer Res 66: 4975\u20134982","journal-title":"Cancer Res"},{"key":"BF6604880_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000071364","volume":"37","author":"JA Baron","year":"2003","unstructured":"Baron JA (2003) Epidemiology of non-steroidal anti-inflammatory drugs and cancer. Prog Exp Tumor Res 37: 1\u201324","journal-title":"Prog Exp Tumor Res"},{"key":"BF6604880_CR5","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1136\/gut.2007.133462","volume":"57","author":"MJ Blaser","year":"2008","unstructured":"Blaser MJ, Chen Y, Reibman J (2008) Does Helicobacter pylori protect against asthma and allergy? Gut 57: 561\u2013567","journal-title":"Gut"},{"key":"BF6604880_CR6","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/sj.bjc.6600820","volume":"88","author":"C Bosetti","year":"2003","unstructured":"Bosetti C, Talamini R, Franceschi S, Negri E, Garavello W, La Vecchia C (2003) Aspirin use and cancers of the upper aerodigestive tract. Br J Cancer 88: 672\u2013674","journal-title":"Br J Cancer"},{"key":"BF6604880_CR7","unstructured":"Breslow NE, Day NE (1987) Statistical methods in cancer research. Vol. 2, The design and analysis of cohort studies. IARC Scientific Publication No. 82, Lyon: IARC"},{"key":"BF6604880_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1054\/bjoc.2000.1121","volume":"83","author":"KK Cheng","year":"2000","unstructured":"Cheng KK, Sharp L, McKinney PA, Logan RF, Chilvers CE, Cook-Mozaffari P, Ahmed A, Day NE (2000) A case\u2013control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer 83: 127\u2013132","journal-title":"Br J Cancer"},{"key":"BF6604880_CR9","first-page":"119","volume":"9","author":"PF Coogan","year":"2000","unstructured":"Coogan PF, Rosenberg L, Palmer JR, Strom BL, Zauber AG, Stolley PD, Shapiro S (2000) Nonsteroidal anti-inflammatory drugs and risk of digestive cancers at sites other than the large bowel. Cancer Epidemiol Biomarkers Prev 9: 119\u2013123","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6604880_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1053\/gast.2003.50008","volume":"124","author":"DA Corley","year":"2003","unstructured":"Corley DA, Kerlikowske K, Verma R, Buffler P (2003) Protective association of aspirin\/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology 124: 47\u201356","journal-title":"Gastroenterology"},{"key":"BF6604880_CR11","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1158\/1055-9965.EPI-07-0664","volume":"17","author":"L Duan","year":"2008","unstructured":"Duan L, Wu AH, Sullivan-Halley J, Bernstein L (2008) Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric adenocarcinomas in Los Angeles County. Cancer Epidemiol Biomarkers Prev 17: 126\u2013134","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6604880_CR12","doi-asserted-by":"publisher","first-page":"365","DOI":"10.7326\/0003-4819-146-5-200703060-00009","volume":"146","author":"C Dub\u00e9","year":"2007","unstructured":"Dub\u00e9 C, Rostom A, Lewin G, Tsertsvadze A, Barrowman N, Code C, Sampson M, Moher D (2007) The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 146: 365\u2013375","journal-title":"Ann Intern Med"},{"key":"BF6604880_CR13","first-page":"97","volume":"7","author":"DC Farrow","year":"1998","unstructured":"Farrow DC, Vaughan TL, Hansten PD, Stanford JL, Risch HA, Gammon MD, Chow WH, Dubrow R, Ahsan H, Mayne ST, Schoenberg JB, West AB, Rotterdam H, Fraumeni Jr JF, Blot WJ (1998) Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 7: 97\u2013102","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6604880_CR14","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.cgh.2007.05.022","volume":"5","author":"J Fortuny","year":"2007","unstructured":"Fortuny J, Johnson CC, Bohlke K, Chow WH, Hart G, Kucera G, Mujumdar U, Ownby D, Wells K, Yood MU, Engel LS (2007) Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers. Clin Gastroenterol Hepatol 5: 1154\u20131159","journal-title":"Clin Gastroenterol Hepatol"},{"key":"BF6604880_CR15","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1093\/aje\/kwm051","volume":"165","author":"ND Freedman","year":"2007","unstructured":"Freedman ND, Abnet CC, Leitzmann MF, Mouw T, Subar AF, Hollenbeck AR, Schatzkin A (2007) A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol 165: 1424\u20131433","journal-title":"Am J Epidemiol"},{"key":"BF6604880_CR16","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1002\/1097-0142(19951001)76:7<1116::AID-CNCR2820760703>3.0.CO;2-I","volume":"76","author":"EM Funkhouser","year":"1995","unstructured":"Funkhouser EM, Sharp GB (1995) Aspirin and reduced risk of esophageal carcinoma. Cancer 76: 1116\u20131119","journal-title":"Cancer"},{"key":"BF6604880_CR17","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1371\/journal.pmed.0040067","volume":"4","author":"PC Galipeau","year":"2007","unstructured":"Galipeau PC, Li X, Blount PL, Maley CC, Sanchez CA, Odze RD, Ayub K, Rabinovitch PS, Vaughan TL, Reid BJ (2007) NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma. PLoS Med 4: e67","journal-title":"PLoS Med"},{"key":"BF6604880_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/(SICI)1097-0215(19961104)68:3<295::AID-IJC5>3.0.CO;2-X","volume":"68","author":"A Garidou","year":"1996","unstructured":"Garidou A, Tzonou A, Lipworth L, Signorello LB, Kalapothaki V, Trichopoulos D (1996) Life-style factors and medical conditions in relation to esophageal cancer by histologic type in a low-risk population. Int J Cancer 68: 295\u2013299","journal-title":"Int J Cancer"},{"key":"BF6604880_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2407-3-28","volume":"3","author":"A Gonzalez-Perez","year":"2003","unstructured":"Gonzalez-Perez A, Garcia Rodriguez LA, Lopez-Ridaura R (2003) Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis. BMC cancer 3: 28","journal-title":"BMC cancer"},{"key":"BF6604880_CR20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/ncpgasthep1138","volume":"5","author":"DY Graham","year":"2008","unstructured":"Graham DY, Shiotani A (2008) New concepts of resistance in the treatment of Helicobacter pylori infections. Nat Clin Pract Gastroenterol Hepatol 5: 321\u2013331","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"BF6604880_CR21","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/jnci\/djk112","volume":"99","author":"EI Heath","year":"2007","unstructured":"Heath EI, Canto MI, Piantadosi S, Montgomery E, Weinstein WM, Herman JG, Dannenberg AJ, Yang VW, Shar AO, Hawk E, Forastiere AA (2007) Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial. J Natl Cancer Inst 99: 545\u2013557","journal-title":"J Natl Cancer Inst"},{"key":"BF6604880_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1586\/14779072.6.1.95","volume":"6","author":"CH Hennekens","year":"2008","unstructured":"Hennekens CH, Schneider WR (2008) The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease. Expert Rev Cardiovasc Ther 6: 95\u2013107","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"BF6604880_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1158\/1940-6207.CAPR-08-0109","volume":"1","author":"F Islami","year":"2008","unstructured":"Islami F, Kamangar F (2008) Helicobacter pylori and Esophageal Cancer Risk: A Meta-analysis. Cancer Prev Res 1: 329\u2013338","journal-title":"Cancer Prev Res"},{"key":"BF6604880_CR24","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/jnci\/djh171","volume":"96","author":"J Jankowski","year":"2004","unstructured":"Jankowski J, Moayyedi P (2004) Re: Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus. J Natl Cancer Inst 96: 885\u2013887","journal-title":"J Natl Cancer Inst"},{"key":"BF6604880_CR25","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/ijc.21814","volume":"119","author":"V Jayaprakash","year":"2006","unstructured":"Jayaprakash V, Menezes RJ, Javle MM, McCann SE, Baker JA, Reid ME, Natarajan N, Moysich KB (2006) Regular aspirin use and esophageal cancer risk. Int J Cancer 119: 202\u2013207","journal-title":"Int J Cancer"},{"key":"BF6604880_CR26","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1002\/cncr.10940","volume":"95","author":"A Kubo","year":"2002","unstructured":"Kubo A, Corley DA (2002) Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States. Cancer 95: 2096\u20132102","journal-title":"Cancer"},{"key":"BF6604880_CR27","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1136\/bmj.320.7250.1642","volume":"320","author":"MJ Langman","year":"2000","unstructured":"Langman MJ, Cheng KK, Gilman EA, Lancashire RJ (2000) Effect of anti-inflammatory drugs on overall risk of common cancer: case\u2013control study in general practice research database. BMJ 320: 1642\u20131646","journal-title":"BMJ"},{"key":"BF6604880_CR28","doi-asserted-by":"publisher","first-page":"4766","DOI":"10.1158\/1078-0432.CCR-06-0693","volume":"12","author":"WK Leung","year":"2006","unstructured":"Leung WK, Ng EKW, Chan FKL, Chan WY, Chan KF, Auyeung ACM, Lam CCH, Lau JYW, Sung JJY (2006) Effects of long-term rofecoxib on gastric intestinal metaplasia: results of a randomized controlled trial. Clin Cancer Res 12: 4766\u20134772","journal-title":"Clin Cancer Res"},{"key":"BF6604880_CR29","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1158\/1055-9965.EPI-04-0467","volume":"14","author":"M Lindblad","year":"2005","unstructured":"Lindblad M, Lagergren J, Garcia Rodriguez LA (2005) Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 14: 444\u2013450","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6604880_CR30","first-page":"70","volume":"32","author":"DS Michaud","year":"2005","unstructured":"Michaud DS, Midthune D, Hermansen S, Leitzmann M, Harlan LC, Kipnis V, Schatzkin A (2005) Comparison of Cancer Registry Case Ascertainment with SEER Estimates and Self-reporting in a Subset of the NIH-AARP Diet and Health Study. Journal of Registry Management 32: 70\u201375","journal-title":"Journal of Registry Management"},{"key":"BF6604880_CR31","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2002","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P (2002) Global cancer statistics 2002. CA Cancer J Clin 55: 74\u2013108","journal-title":"CA Cancer J Clin"},{"key":"BF6604880_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000097947","volume":"74","author":"S Ranka","year":"2006","unstructured":"Ranka S, Gee JM, Johnson IT, Skinner J, Hart AR, Rhodes M (2006) Non-steroidal anti-inflammatory drugs, lower oesophageal sphincter-relaxing drugs and oesophageal cancer. A case\u2013control study. Digestion 74: 109\u2013115","journal-title":"Digestion"},{"key":"BF6604880_CR33","first-page":"3177","volume":"24","author":"LD Ratnasinghe","year":"2004","unstructured":"Ratnasinghe LD, Graubard BI, Kahle L, Tangrea JA, Taylor PR, Hawk E (2004) Aspirin use and mortality from cancer in a prospective cohort study. Anticancer Res 24: 3177\u20133184","journal-title":"Anticancer Res"},{"key":"BF6604880_CR34","volume-title":"SEER Cancer Statistics Review, 1975\u20132004","author":"LAG Ries","year":"2007","unstructured":"Ries LAG, Melbert D (2007) SEER Cancer Statistics Review, 1975\u20132004. National Cancer Institute: Bethesda, MD, USA"},{"key":"BF6604880_CR35","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1158\/1055-9965.EPI-07-2852","volume":"17","author":"S Sadeghi","year":"2008","unstructured":"Sadeghi S, Bain CJ, Pandeya N, Webb PM, Green AC, Whiteman DC (2008) Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the esophagus. Cancer Epidemiol Biomarkers Prev 17: 1169\u20131178","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6604880_CR36","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1093\/aje\/154.12.1119","volume":"154","author":"A Schatzkin","year":"2001","unstructured":"Schatzkin A, Subar AF, Thompson FE, Harlan LC, Tangrea J, Hollenbeck AR, Hurwitz PE, Coyle L, Schussler N, Michaud DS, Freedman LS, Brown CC, Midthune D, Kipnis V (2001) Design and serendipity in establishing a large cohort with wide dietary intake distributions: the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol 154: 1119\u20131125","journal-title":"Am J Epidemiol"},{"key":"BF6604880_CR37","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/00001648-199403000-00003","volume":"5","author":"DM Schreinemachers","year":"1994","unstructured":"Schreinemachers DM, Everson RB (1994) Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 5: 138\u2013146","journal-title":"Epidemiology"},{"key":"BF6604880_CR38","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1038\/sj.bjc.6600945","volume":"88","author":"HT Sorensen","year":"2003","unstructured":"Sorensen HT, Friis S, Norgard B, Mellemkjaer L, Blot WJ, McLaughlin JK, Ekbom A, Baron JA (2003) Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer 88: 1687\u20131692","journal-title":"Br J Cancer"},{"key":"BF6604880_CR39","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/00008469-200006000-00006","volume":"9","author":"UL Suleiman","year":"2000","unstructured":"Suleiman UL, Harrison M, Britton A, McPherson K, Bates T (2000) H2-receptor antagonists may increase the risk of cardio-oesophageal adenocarcinoma: a case\u2013control study. Eur J Cancer Prev 9: 185\u2013191","journal-title":"Eur J Cancer Prev"},{"key":"BF6604880_CR40","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S0140-6736(08)61136-8","volume":"372","author":"NJ Talley","year":"2008","unstructured":"Talley NJ (2008) Is it time to screen and treat H pylori to prevent gastric cancer? The Lancet 372: 350\u2013352","journal-title":"The Lancet"},{"key":"BF6604880_CR41","first-page":"1322","volume":"53","author":"MJ Thun","year":"1993","unstructured":"Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW (1993) Aspirin use and risk of fatal cancer. Cancer Res 53: 1322\u20131327","journal-title":"Cancer Res"},{"key":"BF6604880_CR42","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1365-2036.2004.02150.x","volume":"20","author":"P Tsibouris","year":"2004","unstructured":"Tsibouris P, Hendrickse MT, Isaacs PET (2004) Daily use of non-steroidal anti-inflammatory drugs is less frequent in patients with Barrett's oesophagus who develop an oesophageal adenocarcinoma. Aliment Pharmacol Ther 20: 645\u2013655","journal-title":"Aliment Pharmacol Ther"},{"key":"BF6604880_CR43","doi-asserted-by":"publisher","first-page":"361","DOI":"10.7326\/0003-4819-146-5-200703060-00008","volume":"146","author":"US Preventive Services Task Force","year":"2007","unstructured":"US Preventive Services Task Force (2007) Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 146: 361\u2013364","journal-title":"Ann Intern Med"},{"key":"BF6604880_CR44","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S1470-2045(05)70431-9","volume":"6","author":"TL Vaughan","year":"2005","unstructured":"Vaughan TL, Dong LM, Blount PL, Ayub K, Odze RD, Sanchez CA, Rabinovitch PS, Reid BJ (2005) Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study. Lancet Oncol 6: 945\u2013952","journal-title":"Lancet Oncol"},{"key":"BF6604880_CR45","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1093\/jnci\/djg106","volume":"95","author":"W-H Wang","year":"2003","unstructured":"Wang W-H, Huang J-Q, Zheng G-F, Lam S-K, Karlberg J, Wong BC-Y (2003) Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis. J Natl Cancer Inst 95: 1784\u20131791","journal-title":"J Natl Cancer Inst"},{"key":"BF6604880_CR46","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/(SICI)1097-0215(19990812)82:4<473::AID-IJC1>3.0.CO;2-K","volume":"82","author":"D Zaridze","year":"1999","unstructured":"Zaridze D, Borisova E, Maximovitch D, Chkhikvadze V (1999) Aspirin protects against gastric cancer: results of a case\u2013control study from Moscow, Russia. Int J Cancer 82: 473\u2013476","journal-title":"Int J Cancer"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6604880.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6604880","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6604880.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:37:55Z","timestamp":1684413475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6604880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,20]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["BF6604880"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6604880","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,20]]}}}